Related content

In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy

By Capello Astrid   Krenning Eric   Bernard Bert   Reubi Jean-Claude   Breeman Wout   Jong Marion  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1288-1295

Springer Publishing Company

Access to resources Recommend Favorite

Peptide receptor radionuclide therapy with 90 Y-DOTATOC in recurrent meningioma

By Bartolomei Mirco  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 9, 2009-09 ,pp. : 1407-1416

Springer Publishing Company

Access to resources Recommend Favorite

Receptor radionuclide therapy with ⁹⁰Y-[DOTA]⁰-Tyr³-octreotide (⁹⁰Y-DOTATOC) in neuroendocrine tumours

By Bodei Lisa   Cremonesi Marta   Grana Chiara   Rocca Paola   Bartolomei Mirco   Chinol Marco   Paganelli Giovanni  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 7, 2004-07 ,pp. : 1038-1046

Springer Publishing Company

Access to resources Recommend Favorite

M. Chinol, G. Paganelli (eds): Radionuclide peptide cancer therapy: Taylor & Francis, New York, 2006, Hardback, 351 pages, £110.00, ISBN 0-8247-2887-4

By Modoni Sergio   Urbano Nicoletta  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 7, 2007-07 ,pp. : 1139-1140

Springer Publishing Company

Access to resources Recommend Favorite

Somatostatin receptor scintigraphy using ^99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma

By Czepczyński Rafał   Parisella Maria   Kosowicz Jerzy   Mikołajczak Renata   Ziemnicka Katarzyna   Gryczyńska Maria   Sowiński Jerzy   Signore Alberto  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1635-1645

Springer Publishing Company

Access to resources Recommend Favorite